Total Funding
39
15
Total FundingDebt Financing raised
Growth Score
-1 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
279396
ABT Molecular Imaging develops a production platform to generate unit doses of molecular imaging drugs for PET scanning at the point of use.
Lynda Nutt: Founder
Ronald Nutt: FounderPast Role: CTI Molecular Imaging, Vice President of Research and Developmen
About the Company
ABT Molecular Imaging develops a production platform to generate unit doses of molecular imaging drugs for PET scanning at the point of use.
It was founded by Ron and Lynda Nutt in 2006 and where clinical PET was developed beginning in the early 1980s.
The company was founded in 2006 by industry experts in the molecular imaging industry. ABT’s
investor partners include Intersouth Partners, River Cities Capital, and two TNInvestco Funds, Council & Enhanced Tennessee Fund and Limestone Fund. The company is headquartered in Knoxville, Tennessee.
Women Founded
